Convincing evidence in favour of robotics in total mesorectal excision surgery?
- PMID: 36087609
- DOI: 10.1016/S2468-1253(22)00278-3
Convincing evidence in favour of robotics in total mesorectal excision surgery?
Conflict of interest statement
WAB has received research grants from VIFOR and Braun; consulting fees from Takeda and Braun; and speakers' fees from Takeda, Braun, Medtronic, and Johnson & Johnson. WAB has 4·9% shares in a start-up company, Semiflex, developing vacuum catheters for perianal fistula. RH has received research grants from Stryker; consultancy fees from Stryker and Applied; and speaker's fees from Stryker, Applied, Medtronic, and Johnson & Johnson. Neither author have any interests related to the present comment.
Comment on
-
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial.Lancet Gastroenterol Hepatol. 2022 Nov;7(11):991-1004. doi: 10.1016/S2468-1253(22)00248-5. Epub 2022 Sep 8. Lancet Gastroenterol Hepatol. 2022. PMID: 36087608 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources